Fullerene and placenta extract are two ingredients that sell well on story and create problems on documentation. Both are used in premium capsule serums, both attract regulatory scrutiny in at least some markets, and both are frequently briefed to manufacturers without the paperwork the market will eventually require.
This article is deliberately cautious. It explains what each ingredient is, what the evidence actually supports, and the documentation you should have in hand before you place an order rather than after a shipment is held.
Two ingredients that need documentation before they need marketing
Most cosmetic ingredients are bought on specification and price. These two are different: the questions that decide whether you can sell the finished product are about origin, processing and species, and they are asked by regulators and retailers, not by formulators.
The practical consequence is that the documentation should be assembled during development. Requesting origin and processing records after a batch has been made is slow, and in some cases the answer turns out to be one you cannot use.
Fullerene: what it is and what the evidence supports
Fullerene is a form of carbon - molecules arranged in a closed cage, most commonly C60. In cosmetics it is used as an antioxidant ingredient, and it is most established in Japanese and Korean skincare, where it has been marketed for years.
What can be said responsibly: fullerene has antioxidant properties studied in laboratory settings, and it is used as a cosmetic ingredient in several markets. What cannot be said responsibly: that it outperforms established antioxidants in a way demonstrated on human skin in published, independent trials.
That distinction matters because marketing copy often outruns it. Phrases implying that fullerene "neutralises" a specific number of free radicals, or that it is a superior form of vitamin C, are not supported in the way a regulator or an advertising standards body would expect.
Two practical notes. Fullerene is used at low levels and is expensive, so assay work matters if you are claiming a percentage. And the raw material is dark in colour, which affects the appearance of a light serum - worth checking before you approve packaging.
Placenta extract: what it is, and why sourcing documentation matters
Placental ingredients in cosmetics are derived from animal placenta - most commonly porcine or ovine - and are processed into hydrolysed extracts or protein fractions. Human placenta is not an acceptable cosmetic ingredient and should not appear in any supply chain.
The documentation requirements are the substance of this topic, and they are not negotiable in most markets:
- Species and country of origin. Required for animal-derived materials.
- Processing method. How the material was treated to make it safe for cosmetic use.
- Animal by-product status. Materials of animal origin are subject to specific rules in several jurisdictions, and the classification affects whether the material can be used at all.
- TSE/BSE considerations. Some markets require specific assurances for ruminant-derived materials.
- Viral and microbiological testing appropriate to the material.
Regulatory treatment differs substantially between markets, and it has changed over time. Do not assume that a product sold legally in one country can be sold in another. If placental ingredients are central to your range, confirm status with a regulatory specialist in each target market before development starts.
Regulatory status: a market-by-market question
| Question to answer | Fullerene | Placenta extract |
|---|---|---|
| Is the ingredient permitted in the target market? | Confirm per market; established in some, less clear in others | Confirm per market; animal-origin rules apply |
| Species documentation | Not applicable | Required |
| Processing records | Standard specification | Required, and scrutinised |
| Animal by-product classification | Not applicable | Likely applicable - confirm |
| Retailer acceptance | Generally accepted where legal | Some retailers decline it regardless of legal status |
| Market-specific labelling | Standard INCI listing | Standard INCI listing plus origin records |
Note the retailer row. Some retail channels and marketplaces decline placental ingredients for policy reasons that have nothing to do with legality. If your route to market runs through a major retailer or a marketplace, check its ingredient policy before you develop the product.
Claims: what survives review and what does not
For fullerene, antioxidant and protective claims are the defensible territory, provided they stay cosmetic and are supported by testing on the finished product. Claims that compare it to pharmaceutical actives, or that quantify its effect, are not.
For placenta extract, the historical marketing language is the problem. Claims around regeneration, cellular renewal or reversal of ageing are exactly the kind that attract regulatory action, because they imply biological effects a cosmetic cannot claim. Stick to cosmetic outcomes: moisturisation, skin feel, appearance of smoothness.
In both cases, any claim about the ingredient should be supported by testing on your finished product, not by literature on the raw material. Claim substantiation is covered in our efficacy testing article.
Supply chain: consistency between batches
Both ingredients are supplied in grades that vary. Placental extracts differ by species, by processing and by protein content, which affects colour and odour. Fullerene differs by purity and by dispersion quality, which affects colour and stability.
Colour and odour drift between batches is the most common complaint with both. The control is a reference standard: approve a physical sample from the first commercial batch and require subsequent batches to match it within an agreed range.
Ask also about continuity. If a supplier changes the source of a placental extract mid-contract, your documentation is out of date and your product may need re-approval. Put notification of source changes into the supply agreement.
What to ask your supplier before ordering
- Full INCI name and CAS or equivalent identifier for the exact grade supplied.
- Country of origin and, for animal-derived materials, species.
- Processing method summary and any animal by-product classification.
- Certificate of analysis, with the parameters that actually matter for the grade.
- Confirmation that the supplier will notify you of any change in source or process.
- Safety documentation appropriate to the ingredient and the market.
Ask for these in writing at quotation stage. A supplier who cannot produce them for an animal-derived ingredient is not a supplier you want in your file.
Testing and documentation to request
Beyond the usual release testing, add: assay of the active where a level is claimed, colour and odour assessment against a reference standard, and - for animal-derived materials - microbiological testing appropriate to the material.
Stability work should include the active, not just appearance, and should run in the actual packaging. See our stability testing guide for what to commission.
When the ingredient is worth the cost
Both ingredients are expensive relative to mainstream actives. They are worth it when the story is central to your positioning and your market permits the claim space. They are not worth it when the ingredient is a small part of a formula whose marketing depends on something else, or when the documentation burden delays a launch you cannot afford to delay.
An honest alternative: if the goal is antioxidant positioning, established actives with better-documented evidence profiles may serve better at lower cost and lower regulatory risk. Ask your manufacturer to quote both.
Where our capsule capability fits
We produce capsule serums with specialised actives, including fullerene and placenta capsules, fullerene and sheep placenta single-use capsules, fullerene radiance capsules and fullerene placenta extract capsules. We will tell you which markets these can be documented for, and where alternative actives would serve you better.
We work with brands on private label (your brand on a proven base), OEM/ODM contract manufacturing, and full custom formula development - whichever matches where your brand is today.
Tell us your target markets and we will tell you what documentation is achievable before you commit. Start at our inquiry page, email capsulebiotech@163.com, or reach us on WhatsApp at +86 158-7655-5319 (Capsule Series), +86 158-7655-5319 (Cosmetics Series).
This article is general manufacturing information, not regulatory or legal advice. Ingredient status varies by market and changes over time; confirm requirements with the relevant authority or a qualified regulatory consultant before launching.